AZN Share PerformanceMore
|52 week high||5,520.0 22/06/17|
|52 week low||3,996.0 06/12/16|
|52 week change||-282.0 (-5.45%)|
|4 week volume||55,369,798 31/08/17|
Latest News« previous» nextMore
26/09/2017 - 12:00 RNS
RNS Number: 8473R AstraZeneca PLC 26 September 2017 26 September 2017 12:00 BST TRANSACTION BY PERSON DISCHARGING MANAGERIAL RESPONSIBILITIES Disclosure under Article 19 of the EU Market Abuse Regulation AstraZeneca PLC (the Company) announces that, on 25 September 2017, an award of the Company's American Depositary Shar...
18/09/2017 - 14:41 Interactive Investor
After a busy summer for Neil Woodford, David Brenchley reveals what the star fund manager bought and sold last mon...
14/09/2017 - 11:37 Interactive Investor
Neil Woodford has come in for some criticism after his recent bad patch. Dzmitry Lipski asks whether his three funds ar...
14/09/2017 - 09:24 StockMarketWire
AstraZeneca has entered into an agreement for Aspen Global Incorporated to acquire the residual rights to the established ...
14/09/2017 - 09:00 StockMarketWire
Liberum Capital today downgrades its investment rating on AstraZeneca PLC (LON:AZN) to hold (from buy) and raised ...
14/09/2017 - 07:00 RNS
RNS Number: 6960Q AstraZeneca PLC 14 September 2017 14 September 2017 07:00 BST ASTRAZENECA AND ASPEN ENTER AGREEMENT FOR REMAINING RIGHTS TO ANAESTHETIC MEDICINES Agreement builds on 2016 collaboration on commercialisation rights to anaesthetic medicines in markets outside the US AstraZeneca today announced that it ...
13/09/2017 - 09:20 StockMarketWire
JP Morgan Cazenove today reaffirms its neutral investment rating on AstraZeneca PLC (LON:AZN) and raised its price ta...
11/09/2017 - 16:35 StockMarketWire
A lack of nasty surprises on the geo-political front helped global stocks on Monday. On the London market Petra Diamond...
Latest discussion posts More
“up another 10+%”▼
“Results from a large-scale Phase 3 clinical trial, EXSCEL, assessing the cardiovascular risk of AstraZeneca's (AZN +0.1%) BYDUREON (exenatide extended-release) in type 2 ...”▼
“Neil Woodford, will be pleased and those invested in his funds!!”▼
Codes & Symbols
|Symbols||AZN, LSE:AZN, AZN.L, AZN:LN, LON:AZN, XLON:AZN|